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The self-destructing private sector is no less a blot on our health 
system than the crumbling public health system
The South African private healthcare sector is rightly well regarded for 
its quality of care, including centres of excellence and hotel-style creature 
comforts. Much is made of the foibles of the public health system, but 
private care is in no less an efficiency and sustainability crisis.
My daughter recently needed some dental work. Since she has good 
medical aid coverage through her employer, her dentist suggested that 
the envisaged extraction of 3 teeth be performed on a short-stay basis 
under general anaesthesia at the local private hospital. She was admitted 
and was in the hospital for a total of 3 hours, including 72 minutes in the 
operating theatre. The total bill amounted to a whopping R16 903.68, 
of which R9 270.98, not previously disclosed to her, had to come out 
of her pocket. Ironically, the worst offending tooth – the prime reason 
for in-hospital treatment – was inadvertently left untouched, and was 
subsequently extracted in the dentist’s practice. The cost breakdown 
was as follows:
These extraordinarily exorbitant charges for a minor procedure 
illustrate the conundrum of runaway private healthcare costs that has 
publicly infuriated Health Minister Aaron Motsoaledi, and inspired the 
recent and unprecedented rebellion by members of Discovery Health 
Medical Scheme.
Why is private healthcare so outrageously expensive? The medical 
aid schemes are usually the scapegoat in the public perception, but it 
is the system that is deeply flawed. Medical aid scheme equivalents 
operate successfully in appropriately regulated environments in Western 
Europe. Addressing the US Congress in 2003, Marcia Angell, former 
editor of the New England Journal of Medicine and a fervent campaigner 
for healthcare reform in the USA, said: ‘The underlying problem is 
that we treat healthcare like a market commodity instead of a social 
service. Healthcare is targeted not to medical need, but to the ability to 
pay. Markets are good for many things, but they are not a good way to 
distribute healthcare.’1 Unlike in the USA, South African medical aid 
insurance schemes are not investor-owned and are nominally not for 
profit. However, profit remains a potent driving force behind the high 
cost of private healthcare on the part of the schemes’ administrators, 
providers and suppliers. Discovery Health Medical Scheme, South 
Africa’s largest medical aid with 2.4 million members, is managed by 
Discovery Health, a private, investor-owned, for-profit company that 
derives 90% of its operating profit from its administration fees. 
Private hospital facilities are predominantly owned by three major 
hospital groups, namely Netcare, Medi-Clinic and Life Healthcare, 
all strongly profit driven and listed on the JSE. Collectively, they 
own and operate more than three-quarters of all private sector beds 
and more than 80% of all private sector theatre facilities. Private 
hospitals primarily serve medical aid beneficiaries and look to the 
medical schemes to make their profit. Accordingly, their geographical 
distribution virtually mirrors that of medical aid scheme beneficiaries. 
The monopolistic configuration of the hospital industry means that 
many medical schemes are individually not well placed to negotiate 
competitive rates for hospital services. Schemes are not allowed, in 
terms of a 2004 ruling by the Competition Commissioner, to negotiate 
collectively for competitive rates. Competition regulators clearly treat 
healthcare as a commodity governed by free-market rules. Reference 
price lists for medical service providers are therefore proscribed, giving 
them free rein to charge what the market will bear. Private hospital costs 
accounted for 40.5% of healthcare benefits in the medical scheme risk 
pool in 2010.
The same applies to the procurement of pharmaceuticals, which 
accounted for 14.7% of medical aid disbursements in 2010 according 
to the Council for Medical Schemes, which the state is able to purchase 
at much lower cost for the public sector. As Discovery Heath CEO 
Jonathan Broomberg told the Sunday Independent of 15 July 2012, 
‘new drugs and new technology often come onto the market at prices 
5 or 10 times higher than the older technologies they are replacing’. 
Pharmaceutical pricing is complex, and prices can vary greatly between 
and within countries depending largely on the ability to bargain. Thus 
the same medicines are much cheaper in Canada than in the USA, 
whose private sector and competition regulations are similar to ours. 
The unregulated and unco-ordinated acquisition of sophisticated and 
highly expensive equipment contributes to inefficient use, and is 
ultimately paid for by the medical aids. In some cases, South Africa has 
a higher density of such equipment per population served than OECD 
countries.
The other major contributor to cost escalation is the fee-for-service 
reimbursement system for practitioners. With reference to South Africa, 
Bloomberg and Price have written that ‘The “information gap” between 
doctors and their patients allows doctors to induce demand for their 
services. This leads to the potential for doctors to increase the supply 
of services when they stand to gain financially from doing so. There is 
extensive international evidence, at both national and micro levels, of 
the link between increased utilisation and the fee-for-service payment 
system.’2 Fee-for-service permits fraud in the form of over-claiming, 
false claims, tariff manipulation and over-servicing. These malpractices 
accounted for 76.2% of fraud committed by service providers in a 
KPMG Anti-Fraud Survey reported in the Sunday Independent cited 
above. 
No wonder then that medical aid 
contributions have been increasing 
far above inflation at the same time 
as benefits have been progressively 
trimmed. With National Health 
Insurance apparently still at least 25 
years away from full implementation, 
there is clearly an urgent need for a 
game plan to rescue the private sector 
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Service Medical aid (R) Patient (R) Total (R)
Anaesthesia 2 077.70 3 954.69  6 032.39
Hospital 4 241.00 4 592.09  8 833.00
Dentist 1 314.00    724.20  2 038.20
Totals 7 632.70 9 270.98 16 903.68
